Report by W. Maddox-Jennings in CTNM 10 (1).
Robert
R
Tisserand
D000707:Anaphylaxis / Q000139:chemically induced*; D019341:Aromatherapy / Q000009:adverse effects*; D006801:Humans; D009822:Oils, Volatile / Q000009:adverse effects* / Q000378:metabolism; D010084:Oxidation-Reduction; D012107:Research Design / Q000592:standards; D012449:Safety
D009822:Oils, Volatile